Roquette Announces New Organizational Structure Following IFF Pharma Solutions Acquisition

Roquette, a global leader in plant-based ingredients and pharmaceutical excipients for the health and nutrition sectors, announces today a new organizati...

May 05, 2025 | Monday | News
Recursion Reports Promising Early Results from Phase 2 TUPELO Trial of REC-4881 in Familial Adenomatous Polyposis

In the Phase 2 open-label study, REC-4881 (4 mg QD) led to a median 43% reduction (n=6 patients) in polyp burden at the Week 13 assessment at time of d...

May 05, 2025 | Monday | News
Scorpius Holdings Announces Strategic Update Amid Rising CDMO Demand, Eyes Expansion into Southeast Asia

Scorpius Holdings, Inc. (OTC: SCPX), a biomanufacturing company dedicated to advancing therapeutic production capabilities, today announced a comprehensi...

May 05, 2025 | Monday | News
Exact Sciences CEO Kevin Conroy Highlights Transformative Start to 2025 with Launch of Cologuard Plus and Oncodetect

  Delivered total first quarter revenue of $707 million, an increase of 11% on a reported and core revenue basis, including Screening revenue of ...

May 02, 2025 | Friday | Company results
Crown Bioscience Extends Exclusive Partnership with NEXT Oncology to Advance Translational Cancer Research

Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corp...

May 02, 2025 | Friday | News
PCI Pharma Services Acquires Ajinomoto Althea to Expand Global Sterile Fill-Finish and ADC Capabilities

Along with PCI’s own robust infrastructure expansions, acquisition furthers CDMO’s recent growth in sterile fill-finish, advanced drug delivery...

May 02, 2025 | Friday | News
Roquette Completes Acquisition of IFF Pharma Solutions, Strengthens Global Pharma Leadership

Roquette, a global leader in plant-based ingredients and pharmaceutical excipients for the health and nutrition sectors, announces the successful complet...

May 01, 2025 | Thursday | News
Merck Makes $3.9 Billion Bet on Rare Tumors With SpringWorks Therapeutics Acquisition

  Purchase price of $47 per share in cash represents an enterprise value of €3.0 billion ($3.4 billion), or an equity value of approximately $...

April 29, 2025 | Tuesday | News
Vector BioMed COO Mike Kadan on Reinventing Viral Vector Manufacturing for a Decentralized Gene Therapy Future

In this exclusive interview with BioPharma BoardRoom, Mike Kadan, PhD, MBA, Chief Operating Officer of Vector BioMed, shares how the company is reimagining...

April 25, 2025 | Friday | Interview
Sanofi CEO Paul Hudson Confident in 2025 Growth Trajectory as Q1 Sales Climb 9.7% and Pipeline Delivers Six Approvals

CEO Paul Hudson: Confidence in Full-Year Outlook Paul Hudson, Chief Executive Officer: “We had a strong start in 2025 with sales growth of 9.7%, b...

April 24, 2025 | Thursday | Company results
Adcentrx Therapeutics to Present First Clinical Data for ADC Candidate ADRX-0706 at 2025 ASCO Annual Meeting

Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company redefining Antibody-Drug Conjugate (ADC) therapies for cancer treatment and...

April 24, 2025 | Thursday | News
Antengene to Present Promising Clinical Data on ATG-037 and ATG-008 at 2025 ASCO Annual Meeting

Antengene Corporation Limited, a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commer...

April 24, 2025 | Thursday | News
Manufacture in America, Win in America: Why Big Pharma Is Betting $160 Billion on U.S. Soil

      Global pharmaceutical giants have unveiled over $160 billion in fresh U.S. investments within just the past few...

April 24, 2025 | Thursday | Analysis
Dupixent Secures FDA Nod for Chronic Spontaneous Urticaria in Patients Unresponsive to Antihistamines

Approval based on phase 3 studies demonstrating Dupixent significantly reduced itch and hives compared to placebo In the US, there are more than 300,0...

April 21, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close